| 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design JF Wang, DQ Wei, L Li, SY Zheng, YX Li, KC Chou Biochemical and biophysical research communications 355 (2), 513-519, 2007 | 148 | 2007 |
| Molecular modeling of cytochrome P450 and drug metabolism JF Wang, KC Chou Current drug metabolism 11 (4), 342-346, 2010 | 147 | 2010 |
| Molecular modeling of two CYP2C19 SNPs and its implications for personalized drug design DQ Wei, JF Wang, C Chen, Y Li, KC Chou Protein and peptide letters 15 (1), 27-32, 2008 | 145 | 2008 |
| Drug candidates from traditional chinese medicines JF Wang, DQ Wei, KC Chou Current Topics in Medicinal Chemistry 8 (18), 1656-1665, 2008 | 134 | 2008 |
| Molecular dynamics studies on the interactions of PTP1B with inhibitors: from the first phosphate-binding site to the second one JF Wang, K Gong, DQ Wei, YX Li, KC Chou Protein Engineering, Design & Selection 22 (6), 349-355, 2009 | 117 | 2009 |
| Insight into the molecular switch mechanism of human Rab5a from molecular dynamics simulations JF Wang, KC Chou Biochemical and biophysical research communications 390 (3), 608-612, 2009 | 109 | 2009 |
| Insights from modeling the 3D structure of New Delhi metallo-β-lactamse and its binding interactions with antibiotic drugs JF Wang, KC Chou PLoS One 6 (4), e18414, 2011 | 106 | 2011 |
| Insights from modeling the 3D structure of NAD (P) H-dependent D-xylose reductase of Pichia stipitis and its binding interactions with NAD and NADP JF Wang, DQ Wei, Y Lin, YH Wang, HL Du, YX Li, KC Chou Biochemical and biophysical research communications 359 (2), 323-329, 2007 | 92 | 2007 |
| Structure of cytochrome p450s and personalized drug JF Wang, CC Zhang, KC Chou, DQ Wei Current medicinal chemistry 16 (2), 232-244, 2009 | 90 | 2009 |
| Insights into the mutation-induced HHH syndrome from modeling human mitochondrial ornithine transporter-1 JF Wang, KC Chou PLoS One 7 (1), e31048, 2012 | 83 | 2012 |
| Pharmacogenomics and personalized use of drugs JF Wang, DQ Wei, KC Chou Current topics in medicinal chemistry 8 (18), 1573-1579, 2008 | 82 | 2008 |
| Advances in human cytochrome p450 and personalized medicine Q Chen, T Zhang, JF Wang, DQ Wei Current drug metabolism 12 (5), 436-444, 2011 | 76 | 2011 |
| Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus JF Wang, DQ Wei, KC Chou Biochemical and biophysical research communications 388 (2), 413-417, 2009 | 74 | 2009 |
| Insights from studying the mutation-induced allostery in the M2 proton channel by molecular dynamics JF Wang, KC Chou Protein Engineering, Design & Selection 23 (8), 663-666, 2010 | 69 | 2010 |
| Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor RX Gu, H Gu, ZY Xie, JF Wang, HR Arias, DQ Wei, KC Chou Medicinal Chemistry 5 (3), 250-262, 2009 | 67 | 2009 |
| Computational studies of the binding mechanism of calmodulin with chrysin L Li, DQ Wei, JF Wang, KC Chou Biochemical and biophysical research communications 358 (4), 1102-1107, 2007 | 66 | 2007 |
| An allosteric mechanism inferred from molecular dynamics simulations on phospholamban pentamer in lipid membranes P Lian, DQ Wei, JF Wang, KC Chou PLoS One 6 (4), e18587, 2011 | 65 | 2011 |
| Molecular dynamics studies on T1 lipase: insight into a double-flap mechanism Y Wang, DQ Wei, JF Wang Journal of chemical information and modeling 50 (5), 875-878, 2010 | 59 | 2010 |
| Binding mechanism of H5N1 influenza virus neuraminidase with ligands and its implication for drug design K Gong, L Li, JF Wang, F Cheng, DQ Wei, KC Chou Medicinal Chemistry 5 (3), 242-249, 2009 | 56 | 2009 |
| Reversal of coenzyme specificity and improvement of catalytic efficiency of Pichia stipitis xylose reductase by rational site-directed mutagenesis QK Zeng, HL Du, JF Wang, DQ Wei, XN Wang, YX Li, Y Lin Biotechnology letters 31, 1025-1029, 2009 | 55 | 2009 |
